Dysregulation of KRAS signaling in pancreatic cancer is not associated with KRAS mutations and outcome

Pancreatic ductal adenocarcinoma (PDAC) is a tumor with a poor prognosis, and no targeted therapy is currently available. The aim of the present study was to investigate the prognostic significance of the expression of V-Ki-ras2 Κirsten rat sarcoma viral oncogene homolog (KRAS), downstream signaling...

詳細記述

保存先:
書誌詳細
出版年:Oncol Lett
主要な著者: Lemstrova, Radmila, Brynychova, Veronika, Hughes, David J., Hlavac, Viktor, Dvorak, Pavel, Doherty, Joanne E., Murray, Helena A., Crockard, Martin, Oliverius, Martin, Hlavsa, Jan, Honsova, Eva, Mazanec, Jan, Kala, Zdenek, Lovecek, Martin, Havlik, Roman, Ehrmann, Jiri, Strouhal, Ondrej, Soucek, Pavel, Melichar, Bohuslav, Mohelnikova-Duchonova, Beatrice
フォーマット: Artigo
言語:Inglês
出版事項: D.A. Spandidos 2017
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661609/
https://ncbi.nlm.nih.gov/pubmed/29113235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6946
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料